With its $ 63 billion merger with Allergan in the rearview, the new AbbVie is facing a major challenge as U.S. biosimilars for Humira cast a pall over the near-term future. But AbbVie figures its homegrown prospects will keep driving growth—and a couple of surprises from Allergan could make the forecast even rosier. After six… Read More »
Headaches among children and adolescents in Austria are common, with over 75% experiencing some form of headache, and further research is needed to assess the new diagnostic category of undifferentiated headaches, according to a study published in The Journal of Headache and Pain. The aim of this epidemiological study was to evaluate the prevalence, burden, medication… Read More »
Noninvasive vagal nerve stimulation (nVNS) is effective in aborting attacks in episodic cluster headache and is well tolerated, according to a study published in Cephalalgia. Researchers pooled data from 2 randomized, double-blind, placebo-controlled trials, ACT1 and ACT2, which evaluated nVNS as an acute treatment for cluster headache. There were a total of 225 adults studied with… Read More »
There is a dearth of evidence for diagnostic accuracy in measurement scales that were reported in the literature for headache associated with musculoskeletal symptoms in adults. More studies are required to enhance the level of evidence, according to a study published in Cephalalgia. Researchers conducted a review of literature on the diagnostic accuracy of questionnaires and… Read More »